AAV Production

Power Your Gene Therapy Pipeline with a Proven AAV CDMO Partner

With 30+ years of experience in viral vector development and manufacturing, we bring unmatched expertise as your trusted CDMO for AAV. From plasmids to fill/finish and advanced analytics, we provide true end-to-end support, accelerating your path to the clinic and beyond.

Empowering your AAV-based therapy from preclinical to commercial GMP manufacturing with speed and confidence:

• Our AAV Express Platform delivers scalable, reproducible, and high-performing solutions
• Our tailored tech transfer approach offers a comprehensive and flexible solution to de-risk and scale-up your program
  

Our Track Record

30+

Years of Development and Manufacturing Experience

<12

Months to GMP Batch

50L to 2000L

Clinical to Commercial Scalability

25+

In-house Analytical Assays

>70

AAV Batches Produced

Confidence to Meet Every Milestone

Through a defined process designed by our technical experts you gain confidence in the clinical and commercial manufacturing of your AAV-based gene therapy.

Our AAV platform offers fully comprehensive support to reduce costs and meet your timelines:

• Packaging and transfer plasmids
• GMP-banked HEK293 cell line and media
• Extensive serotype experience
• Optimized GMP production
• On-site fill/ finish services
• Established and customized assays
• Regulatory support services
• Tech transfer capabilities

Discover Our AAV Express Platform

From plasmid design to fill/finish, our AAV Express platform delivers full-spectrum support to streamline production, cut costs, and accelerate your path to clinic and market in 12 months.

High Performance

• 8.5e11 vg/mL harvest titers
• 70-90% full capsids
• 30% recovery

Cost-savings

• Limited process optimization
• Standardized raw materials
• Templated production documents

Proven Scalable Production

• Development: 15mL to 200L
• GMP manufacturing: 50L to 2,000L
• Flexible operations

Technical Expertise

• AAV serotype experience (2, 5, 6, 8, 9, and more)
• 30+ Years of development and manufacturing experience

Comprehensive Analytics

• 25+ In-house panel of pre-qualified assays
• Customized characterization assays
• Onsite in-process and release testing

Regulatory Support

• IND/CTA initial authoring and review
• Submission amendment
• BLA/MAA finalization support

Accelerate Your AAV Therapy to Market with a CDMO You Can Trust

Partner with a team you can trust. Connect with us to discover how our AAV Express platform delivers a cost-effective, de-risked, and streamlined path to GMP production.